Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1.

Chapoval SP, Hritzo M, Qi X, Tamagnone L, Golding A, Keegan AD.

Immunohorizons. 2019 Feb;3(2):71-87. doi: 10.4049/immunohorizons.1800026.

PMID:
31236543
2.

Semaphorins and Their Receptors in Hematological Malignancies.

Wei L, Li H, Tamagnone L, You H.

Front Oncol. 2019 May 9;9:382. doi: 10.3389/fonc.2019.00382. eCollection 2019. Review.

3.

Neuropilins Controlling Cancer Therapy Responsiveness.

Napolitano V, Tamagnone L.

Int J Mol Sci. 2019 Apr 25;20(8). pii: E2049. doi: 10.3390/ijms20082049. Review.

4.

Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.

Gurrapu S, Tamagnone L.

Trends Mol Med. 2019 Apr;25(4):303-314. doi: 10.1016/j.molmed.2019.01.010. Epub 2019 Feb 26. Review.

PMID:
30824197
5.

Semaphorin Signaling in Cancer-Associated Inflammation.

Franzolin G, Tamagnone L.

Int J Mol Sci. 2019 Jan 17;20(2). pii: E377. doi: 10.3390/ijms20020377. Review.

6.

Alveolar Ridge Preservation Using Tridimensional Collagen Matrix and Deproteinized Bovine Bone Mineral in the Esthetic Area: A CBCT and Histologic Human Pilot Study.

Cardaropoli D, Tamagnone L, Roffredo A, De Maria A, Gaveglio L.

Int J Periodontics Restorative Dent. 2018;38(Suppl):s29-s35. doi: 10.11607/prd.3702.

PMID:
30118530
7.

Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies.

Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, Bernards R, Di Nicolantonio F, Giordano S, Tamagnone L.

J Clin Invest. 2018 Aug 31;128(9):3976-3990. doi: 10.1172/JCI99257. Epub 2018 Aug 13.

8.

Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.

Yang YX, Wei L, Zhang YJ, Hayano T, Piñeiro Pereda MDP, Nakaoka H, Li Q, Barragán Mallofret I, Lu YZ, Tamagnone L, Inoue I, Li X, Luo JY, Zheng K, You H.

Clin Exp Metastasis. 2018 Mar;35(3):109-121. doi: 10.1007/s10585-018-9901-2. Epub 2018 Jun 8.

PMID:
29948648
9.

A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.

Gioelli N, Maione F, Camillo C, Ghitti M, Valdembri D, Morello N, Darche M, Zentilin L, Cagnoni G, Qiu Y, Giacca M, Giustetto M, Paques M, Cascone I, Musco G, Tamagnone L, Giraudo E, Serini G.

Sci Transl Med. 2018 May 23;10(442). pii: eaah4807. doi: 10.1126/scitranslmed.aah4807. Erratum in: Sci Transl Med. 2018 Jul 25;10(451):.

10.

Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.

Gurrapu S, Pupo E, Franzolin G, Lanzetti L, Tamagnone L.

Cell Death Differ. 2018 Jul;25(7):1259-1275. doi: 10.1038/s41418-018-0097-4. Epub 2018 Mar 19.

11.

Taming the Notch Transcriptional Regulator for Cancer Therapy.

Tamagnone L, Zacchigna S, Rehman M.

Molecules. 2018 Feb 15;23(2). pii: E431. doi: 10.3390/molecules23020431. Review.

12.

Downregulating Neuropilin-2 Triggers a Novel Mechanism Enabling EGFR-Dependent Resistance to Oncogene-Targeted Therapies.

Rizzolio S, Battistini C, Cagnoni G, Apicella M, Vella V, Giordano S, Tamagnone L.

Cancer Res. 2018 Feb 15;78(4):1058-1068. doi: 10.1158/0008-5472.CAN-17-2020. Epub 2017 Dec 11.

13.

Experimental Approaches for Studying Semaphorin Signals in Tumor Growth and Metastasis in Mouse Models.

Moiso E, Accardo M, Tamagnone L.

Methods Mol Biol. 2017;1493:467-484.

PMID:
27787871
14.
15.

PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.

Rehman M, Gurrapu S, Cagnoni G, Capparuccia L, Tamagnone L.

PLoS One. 2016 Oct 17;11(10):e0164660. doi: 10.1371/journal.pone.0164660. eCollection 2016. Erratum in: PLoS One. 2016 Dec 9;11(12 ):e0168429.

16.

Transmembrane semaphorins: Multimodal signaling cues in development and cancer.

Gurrapu S, Tamagnone L.

Cell Adh Migr. 2016 Nov;10(6):675-691. Epub 2016 Jun 13. Review.

17.

Transmembrane semaphorins, forward and reverse signaling: have a look both ways.

Battistini C, Tamagnone L.

Cell Mol Life Sci. 2016 Apr;73(8):1609-22. doi: 10.1007/s00018-016-2137-x. Epub 2016 Jan 21. Review.

PMID:
26794845
18.

Evaluation of Dental Implants Placed in Preserved and Nonpreserved Postextraction Ridges: A 12-Month Postloading Study.

Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L.

Int J Periodontics Restorative Dent. 2015 Sep-Oct;35(5):677-85. doi: 10.11607/prd.2309.

PMID:
26357697
19.

Bad vessels beware! Semaphorins will sort you out!

Serini G, Tamagnone L.

EMBO Mol Med. 2015 Oct;7(10):1251-3. doi: 10.15252/emmm.201505551. No abstract available.

20.

Soft tissue contour changes at immediate postextraction single-tooth implants with immediate restoration: a 12-month prospective cohort study.

Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L.

Int J Periodontics Restorative Dent. 2015 Mar-Apr;35(2):191-8. doi: 10.11607/prd.2326.

PMID:
25738339
21.

Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence.

Parkash J, Messina A, Langlet F, Cimino I, Loyens A, Mazur D, Gallet S, Balland E, Malone SA, Pralong F, Cagnoni G, Schellino R, De Marchis S, Mazzone M, Pasterkamp RJ, Tamagnone L, Prevot V, Giacobini P.

Nat Commun. 2015 Feb 27;6:6385. doi: 10.1038/ncomms7385.

22.

Coronally advanced flap with and without a xenogenic collagen matrix in the treatment of multiple recessions: a randomized controlled clinical study.

Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L.

Int J Periodontics Restorative Dent. 2014;34 Suppl 3:s97-102. doi: 10.11607/prd.1605.

PMID:
24956099
23.

Brain endothelial cells control fertility through ovarian-steroid-dependent release of semaphorin 3A.

Giacobini P, Parkash J, Campagne C, Messina A, Casoni F, Vanacker C, Langlet F, Hobo B, Cagnoni G, Gallet S, Hanchate NK, Mazur D, Taniguchi M, Mazzone M, Verhaagen J, Ciofi P, Bouret SG, Tamagnone L, Prevot V.

PLoS Biol. 2014 Mar 11;12(3):e1001808. doi: 10.1371/journal.pbio.1001808. eCollection 2014 Mar.

24.

Relationship between the buccal bone plate thickness and the healing of postextraction sockets with/without ridge preservation.

Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L.

Int J Periodontics Restorative Dent. 2014 Mar-Apr;34(2):211-7. doi: 10.11607/prd.1885.

PMID:
24600657
25.

Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.

Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M, Deschoemaeker S, Van Ginderachter JA, Tamagnone L, Mazzone M.

Cancer Cell. 2013 Dec 9;24(6):695-709. doi: 10.1016/j.ccr.2013.11.007.

26.

To die or not to die: Sema3E rules the game.

Tamagnone L, Rehman M.

Cancer Cell. 2013 Nov 11;24(5):564-6. doi: 10.1016/j.ccr.2013.10.010.

27.

Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression.

Cagnoni G, Tamagnone L.

Oncogene. 2014 Oct 2;33(40):4795-802. doi: 10.1038/onc.2013.474. Epub 2013 Nov 11. Review.

28.

Semaphorins in cancer: biological mechanisms and therapeutic approaches.

Rehman M, Tamagnone L.

Semin Cell Dev Biol. 2013 Mar;24(3):179-89. doi: 10.1016/j.semcdb.2012.10.005. Epub 2012 Oct 23. Review.

PMID:
23099250
29.

Neuropilin-1-dependent regulation of EGF-receptor signaling.

Rizzolio S, Rabinowicz N, Rainero E, Lanzetti L, Serini G, Norman J, Neufeld G, Tamagnone L.

Cancer Res. 2012 Nov 15;72(22):5801-11. doi: 10.1158/0008-5472.CAN-12-0995. Epub 2012 Sep 17.

30.

Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer.

Tamagnone L.

Cancer Cell. 2012 Aug 14;22(2):145-52. doi: 10.1016/j.ccr.2012.06.031. Review.

31.

Semaphorin signals tweaking the tumor microenvironment.

Muratori C, Tamagnone L.

Adv Cancer Res. 2012;114:59-85. doi: 10.1016/B978-0-12-386503-8.00003-X. Review.

PMID:
22588056
32.

Socket preservation using bovine bone mineral and collagen membrane: a randomized controlled clinical trial with histologic analysis.

Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L, Cardaropoli G.

Int J Periodontics Restorative Dent. 2012 Aug;32(4):421-30.

PMID:
22577648
33.

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

Casazza A, Kigel B, Maione F, Capparuccia L, Kessler O, Giraudo E, Mazzone M, Neufeld G, Tamagnone L.

EMBO Mol Med. 2012 Mar;4(3):234-50. doi: 10.1002/emmm.201100205. Epub 2012 Jan 13.

34.

Semaphorin signals on the road of endothelial tip cells.

Tamagnone L, Mazzone M.

Dev Cell. 2011 Aug 16;21(2):189-90. doi: 10.1016/j.devcel.2011.07.017.

35.

Multifaceted role of neuropilins in cancer.

Rizzolio S, Tamagnone L.

Curr Med Chem. 2011;18(23):3563-75. Review.

PMID:
21756227
36.

Treatment of gingival recession defects using coronally advanced flap with a porcine collagen matrix compared to coronally advanced flap with connective tissue graft: a randomized controlled clinical trial.

Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L.

J Periodontol. 2012 Mar;83(3):321-8. doi: 10.1902/jop.2011.110215. Epub 2011 Jul 1.

PMID:
21721988
37.

Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models.

Casazza A, Fu X, Johansson I, Capparuccia L, Andersson F, Giustacchini A, Squadrito ML, Venneri MA, Mazzone M, Larsson E, Carmeliet P, De Palma M, Naldini L, Tamagnone L, Rolny C.

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):741-9. doi: 10.1161/ATVBAHA.110.211920. Epub 2011 Jan 4.

38.

Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney.

Perälä N, Jakobson M, Ola R, Fazzari P, Penachioni JY, Nymark M, Tanninen T, Immonen T, Tamagnone L, Sariola H.

Differentiation. 2011 Feb;81(2):81-91. doi: 10.1016/j.diff.2010.10.001. Epub 2010 Oct 30.

PMID:
21035938
39.

The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth.

Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM, Tamagnone L.

J Biol Chem. 2010 Dec 10;285(50):38756-64. doi: 10.1074/jbc.M110.145417. Epub 2010 Oct 11.

40.

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.

Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L.

J Clin Invest. 2010 Aug;120(8):2684-98. doi: 10.1172/JCI42118. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945. Mazzone, Massimilano [corrected to Mazzone, Massimiliano].

41.

Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression.

Valente G, Nicotra G, Arrondini M, Castino R, Capparuccia L, Prat M, Kerim S, Tamagnone L, Isidoro C.

Cell Oncol. 2009;31(6):423-36. doi: 10.3233/CLO-2009-0504.

42.

Overexpression of GAP-43 modifies the distribution of the receptors for myelin-associated growth-inhibitory proteins in injured Purkinje axons.

Foscarin S, Gianola S, Carulli D, Fazzari P, Mi S, Tamagnone L, Rossi F.

Eur J Neurosci. 2009 Nov;30(10):1837-48. doi: 10.1111/j.1460-9568.2009.06985.x. Epub 2009 Nov 6.

PMID:
19895561
43.

Structure and function of the intracellular region of the plexin-b1 transmembrane receptor.

Tong Y, Hota PK, Penachioni JY, Hamaneh MB, Kim S, Alviani RS, Shen L, He H, Tempel W, Tamagnone L, Park HW, Buck M.

J Biol Chem. 2009 Dec 18;284(51):35962-72. doi: 10.1074/jbc.M109.056275.

44.

The semaphorin 4D-plexin-B signalling complex regulates dendritic and axonal complexity in developing neurons via diverse pathways.

Vodrazka P, Korostylev A, Hirschberg A, Swiercz JM, Worzfeld T, Deng S, Fazzari P, Tamagnone L, Offermanns S, Kuner R.

Eur J Neurosci. 2009 Oct;30(7):1193-208. doi: 10.1111/j.1460-9568.2009.06934.x. Epub 2009 Sep 29.

PMID:
19788569
45.

Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.

Balakrishnan A, Penachioni JY, Lamba S, Bleeker FE, Zanon C, Rodolfo M, Vallacchi V, Scarpa A, Felicioni L, Buck M, Marchetti A, Comoglio PM, Bardelli A, Tamagnone L.

Hum Mutat. 2009 Aug;30(8):1167-74. doi: 10.1002/humu.21017.

46.

Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.

Capparuccia L, Tamagnone L.

J Cell Sci. 2009 Jun 1;122(Pt 11):1723-36. doi: 10.1242/jcs.030197. Review.

47.

Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex.

Giacobini P, Messina A, Morello F, Ferraris N, Corso S, Penachioni J, Giordano S, Tamagnone L, Fasolo A.

J Cell Biol. 2008 Nov 3;183(3):555-66. doi: 10.1083/jcb.200806160.

48.

Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

Franco M, Tamagnone L.

EMBO Rep. 2008 Sep;9(9):865-71. doi: 10.1038/embor.2008.139. Epub 2008 Jul 25. Review.

49.

Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages.

Sierra JR, Corso S, Caione L, Cepero V, Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H, Comoglio PM, Tamagnone L, Giordano S.

J Exp Med. 2008 Jul 7;205(7):1673-85. doi: 10.1084/jem.20072602. Epub 2008 Jun 16.

50.

The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment.

Rolny C, Capparuccia L, Casazza A, Mazzone M, Vallario A, Cignetti A, Medico E, Carmeliet P, Comoglio PM, Tamagnone L.

J Exp Med. 2008 May 12;205(5):1155-71. doi: 10.1084/jem.20072509. Epub 2008 May 5.

Supplemental Content

Loading ...
Support Center